BR0111726A - Derivados de biotina - Google Patents

Derivados de biotina

Info

Publication number
BR0111726A
BR0111726A BR0111726-2A BR0111726A BR0111726A BR 0111726 A BR0111726 A BR 0111726A BR 0111726 A BR0111726 A BR 0111726A BR 0111726 A BR0111726 A BR 0111726A
Authority
BR
Brazil
Prior art keywords
biotin derivatives
body fluids
extracorporeal
toxic material
mammalian
Prior art date
Application number
BR0111726-2A
Other languages
English (en)
Inventor
Bengt Sandberg
Scott Wilbur
Rune Nilsson
Original Assignee
Mitra Medical Technology Ab
Dept Of Radiation Oncology Uni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0002287A external-priority patent/SE0002287D0/xx
Application filed by Mitra Medical Technology Ab, Dept Of Radiation Oncology Uni filed Critical Mitra Medical Technology Ab
Publication of BR0111726A publication Critical patent/BR0111726A/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin, biotin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"DERIVADOS DE BIOTINA". Um método para o condicionamento de um dispositivo extracorpóreo é descrito, bem como método para extração extracorpórea de material tóxico de fluidos de corpo de mamífero com relação a diagnose ou tratamento de uma condição ou doença de mamífero, em cujos métodos reagentes tendo a capacidade de extrair material tóxico de fluidos de corpo de mamífero são envolvidos, e um dispositivo extracorpóreo compreendendo o referido reagente.
BR0111726-2A 2000-06-16 2001-06-18 Derivados de biotina BR0111726A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0002287A SE0002287D0 (sv) 2000-06-16 2000-06-16 Biotinderivat
US21662500P 2000-07-07 2000-07-07
PCT/SE2001/001374 WO2001095857A2 (en) 2000-06-16 2001-06-18 Reusable extracorporeal colums loaded with ligand-dibiotin conjugates

Publications (1)

Publication Number Publication Date
BR0111726A true BR0111726A (pt) 2003-05-27

Family

ID=26655149

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111726-2A BR0111726A (pt) 2000-06-16 2001-06-18 Derivados de biotina

Country Status (14)

Country Link
EP (1) EP1289563B1 (pt)
JP (1) JP2004503299A (pt)
CN (1) CN1457260A (pt)
AT (1) ATE469661T1 (pt)
AU (2) AU7476101A (pt)
BR (1) BR0111726A (pt)
CA (1) CA2412495C (pt)
DE (1) DE60142286D1 (pt)
HU (1) HUP0401953A3 (pt)
IL (1) IL153449A0 (pt)
MX (1) MXPA02012438A (pt)
NO (1) NO20025931L (pt)
PL (1) PL359328A1 (pt)
WO (1) WO2001095857A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1813614B1 (en) * 2006-01-25 2011-10-05 Sanofi Cytotoxic agents comprising new tomaymycin derivatives
PL2220107T3 (pl) 2007-11-12 2017-05-31 Chreto Aps Polipeptydy o podwójnym powinowactwie do oczyszczania
CA2837586C (en) * 2011-05-27 2018-12-11 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
WO2012166559A1 (en) * 2011-05-27 2012-12-06 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
JP6096371B2 (ja) * 2014-02-18 2017-03-15 サヴィッド・セラピューティックス株式会社 ビオチン改変体、ストレプトアビジン変異体およびそれらの利用
CN106166311B (zh) * 2016-08-30 2018-07-13 张小曦 一种血浆净化系统及其应用
KR20210123427A (ko) * 2016-12-27 2021-10-13 에프. 호프만-라 로슈 아게 신규한 비오틴-특이적 단일클론 항체 및 그 용도
JP7174951B2 (ja) * 2017-02-17 2022-11-18 三井化学株式会社 抗体医薬の開発に資する創薬標的タンパク質の同定方法及び標的タンパク質に対する抗体の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100142L (sv) * 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal
US5482698A (en) * 1993-04-22 1996-01-09 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin polymer conjugates
JP3441530B2 (ja) * 1994-10-03 2003-09-02 株式会社セルシード 温度応答型分離材料及びその製造方法
JP3300583B2 (ja) * 1995-11-10 2002-07-08 幹男 中山 抗原又は抗体の検出シート、検出キット及び検出方法
WO1997029114A1 (en) * 1996-02-08 1997-08-14 Board Of Regents Of The University Of Washington Biotin-containing compounds, biotinylation reagents and methods

Also Published As

Publication number Publication date
MXPA02012438A (es) 2004-09-06
AU2001274761B2 (en) 2005-06-16
NO20025931L (no) 2003-02-14
EP1289563B1 (en) 2010-06-02
WO2001095857A3 (en) 2002-03-28
WO2001095857A2 (en) 2001-12-20
CN1457260A (zh) 2003-11-19
IL153449A0 (en) 2003-07-06
DE60142286D1 (de) 2010-07-15
PL359328A1 (en) 2004-08-23
JP2004503299A (ja) 2004-02-05
AU7476101A (en) 2001-12-24
EP1289563A2 (en) 2003-03-12
HUP0401953A3 (en) 2005-06-28
ATE469661T1 (de) 2010-06-15
NO20025931D0 (no) 2002-12-11
HUP0401953A2 (hu) 2004-12-28
CA2412495C (en) 2011-02-01
CA2412495A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
DE602006008774D1 (de) Kanüleneinführungssystem
MXPA04000062A (es) Miembros de drenaje extensibles para conectar a tierra la proteccion por interferencia electromagnetica/interferencia por radiofrecuencia.
BRPI0411013A (pt) implante para uso na fusão de estruturas ósseas adjacentes, método de tratar um organismo para promover fusão de estruturas ósseas adjacentes e sistema para uso na fusão de estruturas ósseas adjacentes
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
DE60329165D1 (de) Detektion und/oder beobachtung von synuclein-assoziierten krankheiten
WO2002018652A3 (en) Method for detection of htr and htert telomerase-associated rna in plasma or serum
BR0316111A (pt) Métodos para diagnosticar rcc e outros tumores sólidos
BRPI0413350A (pt) dispositivo e métodos para coleta de amostra de fluido biológico e tratamento de componentes selecionados
AU7494701A (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
WO2006086561A3 (en) Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
BR0110091A (pt) Composições e processos para terapia e diagnóstico de câncer de mama
ATE336506T1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
BR0111726A (pt) Derivados de biotina
SE0002287D0 (sv) Biotinderivat
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
BR0211922A (pt) Método para secagem de artigos de tecido contendo fluido lipofìlico, sistema de secagem dos referidos artigos, bem como artigo de tecido assim obtido
BR0110512A (pt) Preparação para medir a taxa de esvaziamento gástrico
WO2003001182A3 (en) Homocysteinylated transthyretin
BR0316599A (pt) Agentes de alvejamento anti-linfoma com funções efetoras e de afinidade ligadas por um reagente trifuncional
PT1242825E (pt) Extraccao de lipoproteinas a partir de fluidos corporais
ATE382678T1 (de) Verfahren zur diagnose von rickettsia pulicis
ES2074983T3 (es) Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.
WO2003061622A3 (de) Verfahren und vorrichtumg tum einbringen von lebenden zellen in eine biologische körperflüssigkeit
DE60144027D1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
ATE151816T1 (de) Nachweis synthetischer oligonucleotide extrahiert aus körperflüssigkeiten oder geweben:

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009.

B15K Others concerning applications: alteration of classification

Ipc: B01D 15/38 (2006.01)